Stay updated on Emricasan in NASH Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Emricasan in NASH Fibrosis Clinical Trial page.

Latest updates to the Emricasan in NASH Fibrosis Clinical Trial page
- CheckyesterdayChange DetectedSteatotic Liver Disease has been added and Fatty Liver Disease removed from the page's keyword taxonomy, reflecting updated naming conventions for liver conditions and affecting how the study is indexed and discovered.SummaryDifference0.1%

- Check8 days agoChange DetectedThe page now shows Revision: v3.6.3 instead of v3.6.2, signaling a small underlying update to the site version rather than a modification to study details.SummaryDifference0.0%

- Check16 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, indicating a new revision in the page history.SummaryDifference0.0%

- Check30 days agoChange DetectedThe study page now shows recruitment status 'No longer looking for participants', indicating enrollment is closed. It also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment heading while removing the older revision label.SummaryDifference0.2%

- Check37 days agoChange DetectedThe revision label on the page was updated from v3.5.4 to v3.5.5, signaling a minor update to the page's software/metadata without changing the study information.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page shows a revised version label, updating from v3.5.3 to v3.5.4, reflecting a software/template update rather than a change to the trial's details.SummaryDifference0.0%

Stay in the know with updates to Emricasan in NASH Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Emricasan in NASH Fibrosis Clinical Trial page.